Samtidig administration af EMEND og ergotalkaloidderivater, der er CYP3A4- substrater, kan resultere i forhøjede plasmakoncentrationer af disse aktive substanser.
Co-administration of EMEND with ergot alkaloid derivatives, which are CYP3A4 substrates, may result in elevated plasma concentrations of these active substances.